Three-gene signature predictive of high residual risk of recurrence after adjuvant chemotherapy in ER-positive HER2-negative breast cancer

被引：0
|
作者：
Gyorffy, B.
Ocana, A.
Herman, P.
Hatzis, C.
Pandiella, A.
Pusztai, L.
机构：
[1] Yale Univ, New Haven, CT 06520 USA
[2] Servicoio Salud Castilla la Mancha, Albacete, Spain
[3] MTA TTK, Budapest, Hungary
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P6-09-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-09-49
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer
    Fujiki, Y.
    Yamamoto, Y.
    Yamamoto-Ibusuki, M.
    Goto, R.
    Tomiguchi, M.
    Sueta, A.
    Takeshita, T.
    Iwase, H.
    CANCER RESEARCH, 2017, 77
  • [2] Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
    Richard Buus
    Belinda Yeo
    Adam R. Brentnall
    Marie Klintman
    Maggie Chon U. Cheang
    Komel Khabra
    Ivana Sestak
    Qiong Gao
    Jack Cuzick
    Mitch Dowsett
    Breast Cancer Research, 20
  • [3] Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
    Buus, Richard
    Yeo, Belinda
    Brentnall, Adam R.
    Klintman, Marie
    Cheang, Maggie Chon U.
    Khabra, Komel
    Sestak, Ivana
    Gao, Qiong
    Cuzick, Jack
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2018, 20
  • [4] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [5] Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer
    Hageman, Elizabeth
    Lussier, Mia E.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 849 - 856
  • [6] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Takeo Fujii
    Hiroko Masuda
    Yee Chung Cheng
    Fei Yang
    Aysegul A. Sahin
    Yasuto Naoi
    Yuki Matsunaga
    Akshara Raghavendra
    Arup Kumar Sinha
    Jose Rodrigo Espinosa Fernandez
    Anjali James
    Keisuke Yamagishi
    Tomoko Matsushima
    Robert Schuetz
    Debu Tripathy
    Sachiyo Tada
    Rubie S. Jackson
    Shinzaburo Noguchi
    Seigo Nakamura
    Jared D. Acoba
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2021, 189 : 455 - 461
  • [7] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara
    Sinha, Arup Kumar
    Fernandez, Jose Rodrigo Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Schuetz, Robert
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared D.
    Ueno, Naoto T.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 455 - 461
  • [8] Elacestrant in advanced ER-positive, HER2-negative breast cancer
    Kuenzell, Judith Lorenz
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01) : 16 - 16
  • [9] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ho Hyun Ryu
    Sei Hyun Ahn
    Seon Ok Kim
    Jeong Eun Kim
    Ji sun Kim
    Jin-Hee Ahn
    Kyung Hae Jung
    Sung-Bae Kim
    Beom Seok Ko
    Jong Won Lee
    Byung Ho Son
    Hee Jung Shin
    Hak Hee Kim
    Gyung yub Gong
    Hee Jeong Kim
    Scientific Reports, 11
  • [10] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ryu, Ho Hyun
    Ahn, Sei Hyun
    Kim, Seon Ok
    Kim, Jeong Eun
    Kim, Ji Sun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Shin, Hee Jung
    Kim, Hak Hee
    Gong, Gyung Yub
    Kim, Hee Jeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345